Access To Medicine Index
AMSTERDAM, June 20, 2010 - Generic drug makers are less transparent about programs to make medicines
available to people in developing countries than originator companies in
Europe and the United States.
AMSTERDAM, June 20, 2010 - Generic drug makers in general are less transparent about programs to
make medicines available to people in developing countries than originator
companies in Europe and the United States.
AMSTERDAM, June 20, 2010 - European pharmaceutical companies outcompete their U.S.
AMSTERDAM, June 20, 2010 - For the first time, Japanese pharmaceutical companies were ranked with
their U.S.
